EWP
CGEN icon

Engrave Wealth Partners’s Compugen CGEN Stock Holding History

Engrave Wealth Partners’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-590
Closed -$8K – 120
2020
Q2 		$8K Buy
590
+290
+97% +$3.91K 0.01% 266
2020
Q1 		$2K Hold
300
– – ﹤0.01% 343
2019
Q4 		$1K Buy
+300
New +$1.54K ﹤0.01% 413

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Engrave Wealth Partners's CGEN Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Compugen (CGEN) in Q3 2020, closing a stake of 590 shares — an estimated $8K sold.

Engrave Wealth Partners first reported a position in CGEN in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 107 funds tracked by Wall St. Rank hold CGEN as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Compugen position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 590 Compugen shares in Q3 2020, an estimated $8K.
  • Engrave Wealth Partners first reported a position in Compugen in Q4 2019 and held it in 3 quarters.
  • Engrave Wealth Partners's Compugen position peaked at $8K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Compugen as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.